PAVmed Inc. (PAVM)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 1.5M 3M 4.5M Q3 '24: 4M Q4 '24: 3M Q1 '25: 2M Q2 '25: 1M Q3 '25: 29K Q4 '25: 71K Q1 '26: 85K Q2 '26: 112K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit TTM

-300K -200K -100K 0 100K 200K 300K Q2 '22: -265K Q2 '22

Operating Income TTM

-60M -40M -20M 0 20M 40M 60M Q3 '24: -55.7M Q4 '24: -44.5M Q1 '25: -35.9M Q2 '25: -26.9M Q3 '25: -20.2M Q4 '25: -21.8M Q1 '26: -24.4M Q2 '26: -26.7M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income TTM

-30M 0 30M 60M 90M Q3 '24: 24.3M Q4 '24: 39.8M Q1 '25: 74M Q2 '25: 72.9M Q3 '25: 3.1M Q4 '25: 401K Q1 '26: -18.6M Q2 '26: -12.1M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue TTM

0 2.5M 5M 7.5M Q3 '24: 6.4M Q4 '24: 4.8M Q1 '25: 3.1M Q2 '25: 1.5M Q3 '25: 180K Q4 '25: 217K Q1 '26: 278K Q2 '26: 359K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow TTM

-60M -40M -20M 0 20M 40M 60M Q3 '24: -45.5M Q4 '24: -33.6M Q1 '25: -22M Q2 '25: -11.5M Q3 '25: -3.6M Q4 '25: -5.2M Q1 '26: -6.2M Q2 '26: -7.7M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow TTM

-60M -40M -20M 0 20M 40M 60M Q3 '24: -45.8M Q4 '24: -33.6M Q1 '25: -22M Q2 '25: -11.6M Q3 '25: -3.6M Q4 '25: -5.2M Q1 '26: -6.3M Q2 '26: -7.8M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q1 '24: 8.7M Q2 '24: 9.2M Q3 '24: 44.5M Q1 '25: 1.7M Q2 '25: 602.8K Q3 '25: 21.6M Q1 '26: 1.6M Q2 '26: 6.3M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-18.00 -9.00 0.00 9.00 18.00 27.00 Q1 '24: -9.03 Q2 '24: -8.12 Q3 '24: -4.30 Q4 '24: 11.74 Q1 '25: 24.46 Q2 '25: 3.57 Q3 '25: 1.84 Q4 '25: -5.63 Q1 '24 Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.